GlassScriptPhysician profile
Louis Cubba
NPI 1649201716
$350,903.24
in general payments reported to CMS, 2019-2025
5 companies · $58K in 2025
The $58K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47K · 2020: $21K · 2021: $36K · 2022: $58K · 2023: $58K · 2024: $72K · 2025: $58K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $151K · Travel and Lodging: $19K · Consulting Fee: $13K · Food and Beverage: $5,417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $150,715.00 |
| Travel and Lodging | $18,756.62 |
| Consulting Fee | $13,365.00 |
| Food and Beverage | $5,416.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $198,268.54 | 2019-2025 | Apretude, Rukobia, Cabenuva |
| Gilead Sciences, INC. | $151,236.28 | 2019-2025 | Descovy, Biktarvy, Yeztugo |
| Shionogi INC | $975.00 | 2025 | S-217622 |
| Merck Sharp & Dohme LLC | $324.42 | 2019 | |
| Janssen Products, LP | $99.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Louis Cubba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.